Document is current
Any future updates will be listed below
-
Authors
Kusnadi, Eric P https://orcid.org/0000-0002-6278-1864
Trigos, Anna S https://orcid.org/0000-0002-5915-2952
Cullinane, Carleen https://orcid.org/0000-0001-5833-6605
Goode, David L
Larsson, Ola https://orcid.org/0000-0003-1412-1308
Devlin, Jennifer R
Chan, Keefe T https://orcid.org/0000-0001-6114-3724
De Souza, David P
McConville, Malcolm J https://orcid.org/0000-0002-7107-7887
McArthur, Grant A
Thomas, George https://orcid.org/0000-0002-1236-1714
Sanij, Elaine https://orcid.org/0000-0002-2063-7813
Poortinga, Gretchen
Hannan, Ross D
Hannan, Katherine M
Kang, Jian https://orcid.org/0000-0001-9998-4975
Pearson, Richard B https://orcid.org/0000-0001-5919-5090
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1154540)
Department of Health | National Health and Medical Research Council (1106576)
Department of Health | National Health and Medical Research Council (1116999)
Department of Health | National Health and Medical Research Council (1058586)
Department of Health | National Health and Medical Research Council (1158732)
Department of Health | National Health and Medical Research Council (1053792)
Department of Health | National Health and Medical Research Council (1102609)
Department of Health | National Health and Medical Research Council (1053792)
Victorian Cancer Agency (MCRF19007)
- License Information
-
More Information
Article History
Received: 26 March 2020
Revised: 4 August 2020
Accepted: 8 August 2020
First Online: 18 September 2020
Conflict of interest
: G.A. McArthur reports receiving commercial research grants from Celgene, Novartis, and Ventana and is a consultant/advisory board member for Provectus. R.D. Hannan is a consultant/advisory board member for Pimera, Inc. No potential conflicts of interest were disclosed by the other authors.
